Literature DB >> 29689541

Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease.

Judith S Currier1.   

Abstract

HIV-infected individuals on effective antiretroviral therapy experience a number of non-AIDS noncommunicable diseases, such as cardiovascular disease, more frequently than uninfected individuals. Common pathways for such diseases are chronic immune activation and inflammation, including the prolonged inflammation associated with lower nadir CD4+ cell count. Prevention and treatment of non-AIDS conditions include treatment of traditional risk factors, lifestyle interventions, earlier initiation of antiretroviral therapy, and potentially therapies specifically targeting inflammation and immune activation (eg, statins). This article summarizes a presentation by Judith S. Currier, MD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in New York, New York, in February 2017.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29689541      PMCID: PMC5935217     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  38 in total

1.  Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.

Authors:  Todd T Brown; Carlee Moser; Judith S Currier; Heather J Ribaudo; Jennifer Rothenberg; Theodoros Kelesidis; Otto Yang; Michael P Dubé; Robert L Murphy; James H Stein; Grace A McComsey
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

2.  Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study.

Authors:  Jessica R White; Chung-Chou H Chang; Kaku A So-Armah; Jesse C Stewart; Samir K Gupta; Adeel A Butt; Cynthia L Gibert; David Rimland; Maria C Rodriguez-Barradas; David A Leaf; Roger J Bedimo; John S Gottdiener; Willem J Kop; Stephen S Gottlieb; Matthew J Budoff; Tasneem Khambaty; Hilary A Tindle; Amy C Justice; Matthew S Freiberg
Journal:  Circulation       Date:  2015-09-10       Impact factor: 29.690

3.  Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.

Authors:  Nicholas T Funderburg; Ying Jiang; Sara M Debanne; Norma Storer; Danielle Labbato; Brian Clagett; Janet Robinson; Michael M Lederman; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2013-11-18       Impact factor: 9.079

4.  Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.

Authors:  Ashwin Balagopal; David M Asmuth; Wei-Teng Yang; Thomas B Campbell; Nikhil Gupte; Laura Smeaton; Cecilia Kanyama; Beatriz Grinsztejn; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh G Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Xiao-Dong Li; Richard B Pollard; Richard D Semba; David L Thomas; Robert C Bollinger; Amita Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.731

5.  Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study.

Authors:  Rebecca A Legarth; Magnus G Ahlström; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Gitte Pedersen; Rajesh Mohey; Jan Gerstoft; Niels Obel
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

6.  Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013.

Authors:  Matthew J Feinstein; Ehete Bahiru; Chad Achenbach; Christopher T Longenecker; Priscilla Hsue; Kaku So-Armah; Matthew S Freiberg; Donald M Lloyd-Jones
Journal:  Am J Cardiol       Date:  2015-11-06       Impact factor: 2.778

7.  Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.

Authors:  Michael J Silverberg; Wendy Leyden; Leo Hurley; Alan S Go; Charles P Quesenberry; Daniel Klein; Michael A Horberg
Journal:  Ann Intern Med       Date:  2009-03-03       Impact factor: 25.391

8.  Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.

Authors:  Sonja M Bjerk; Jason V Baker; Sean Emery; Jacqueline Neuhaus; Brian Angus; Fred M Gordin; Sarah L Pett; Christoph Stephan; Ken M Kunisaki
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

9.  Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic resonance feasibility study.

Authors:  Mariana Diaz-Zamudio; Damini Dey; Troy LaBounty; Michael Nelson; Zhaoyang Fan; Lidia S Szczepaniak; Bill Pei-Chin Hsieh; Ronak Rajani; Daniel Berman; Debiao Li; Rohan Dharmakumar; W David Hardy; Antonio Hernandez Conte
Journal:  J Cardiovasc Magn Reson       Date:  2015-10-31       Impact factor: 5.364

10.  Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.

Authors:  Caroline A Sabin; Peter Reiss; Lene Ryom; Andrew N Phillips; Rainer Weber; Matthew Law; Eric Fontas; Amanda Mocroft; Stephane de Wit; Colette Smith; Francois Dabis; Antonella d'Arminio Monforte; Wafaa El-Sadr; Jens D Lundgren
Journal:  BMC Med       Date:  2016-03-31       Impact factor: 8.775

View more
  3 in total

Review 1.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

2.  "If it weren't for my traditional healer, I would be dead": Engaging traditional healers to support people living with HIV in rural Mozambique.

Authors:  Carolyn M Audet; Mariah Pettapiece-Phillips; Yuqi Tian; Bryan E Shepherd; Sten H Vermund; Jose Salato
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

Review 3.  Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity.

Authors:  John M Curtin; Naomi E Aronson
Journal:  Microorganisms       Date:  2021-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.